Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 201: Which of the following can be utilized to determine if a drug is a competitive or non-competitive inhibitor?

A. Potency
B. Dose-Response Curve (DRC) (Correct Answer)
C. Efficacy
D. All of the above

Explanation: ### Explanation The **Dose-Response Curve (DRC)** is the gold standard for distinguishing between competitive and non-competitive inhibition because it visually represents the relationship between drug concentration and pharmacological effect. **1. Why DRC is the correct answer:** * **Competitive Inhibition:** The inhibitor competes for the same binding site as the agonist. This can be overcome by increasing the agonist concentration. On a DRC, this results in a **rightward shift** (increased $EC_{50}$/decreased potency) while the **maximal response ($E_{max}$) remains unchanged**. * **Non-competitive Inhibition:** The inhibitor binds to an allosteric site or irreversibly to the active site. Increasing the agonist concentration cannot overcome this. On a DRC, this results in a **downward shift** (decreased $E_{max}$/efficacy), while the $EC_{50}$ typically remains the same. **2. Why other options are incorrect:** * **Potency (A):** Potency refers to the amount of drug needed to produce an effect. While competitive inhibitors decrease potency, simply knowing a drug's potency doesn't tell you the *mechanism* of inhibition without seeing the effect on $E_{max}$. * **Efficacy (C):** Efficacy is the maximal response a drug can produce. While non-competitive inhibitors decrease efficacy, observing a change in efficacy alone doesn't provide the full comparative picture offered by the entire curve. * **All of the above (D):** Incorrect because only the complete DRC provides the simultaneous data on both $EC_{50}$ and $E_{max}$ required to differentiate the two. **High-Yield NEET-PG Pearls:** * **Competitive:** Surmountable; Parallel shift to the right; $V_{max}$ constant, $K_m$ increases (Lineweaver-Burk plot). * **Non-competitive:** Insurmountable; Non-parallel downward shift; $V_{max}$ decreases, $K_m$ constant. * **Example:** Atropine is a competitive antagonist of Acetylcholine; Aspirin is an irreversible (non-competitive) inhibitor of COX enzymes.

Question 202: Which of the following is a prodrug?

A. Enalapril (Correct Answer)
B. Clonidine
C. Salmeterol
D. Acetazolamide

Explanation: **Explanation:** **Correct Option: A (Enalapril)** A **prodrug** is a pharmacologically inactive compound that must undergo metabolic conversion (usually in the liver) to become an active metabolite [1]. **Enalapril** is an ester prodrug that is hydrolyzed by hepatic esterases into its active form, **Enalaprilat** [2]. Most ACE inhibitors are prodrugs designed to improve oral bioavailability, with two notable exceptions: **Lisinopril and Captopril** (which are active as such) [3]. **Incorrect Options:** * **B. Clonidine:** An alpha-2 adrenergic agonist used in hypertension. It is an active drug and does not require metabolic activation. * **C. Salmeterol:** A long-acting beta-2 agonist (LABA) used in asthma. It is active upon administration to the respiratory tract. * **D. Acetazolamide:** A carbonic anhydrase inhibitor used in glaucoma and mountain sickness. It is an active drug excreted largely unchanged by the kidneys. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Exceptions:** Remember the mnemonic **"L-C"** (Lisinopril and Captopril) are NOT prodrugs. All other ACE inhibitors (Ramipril, Perindopril, etc.) are prodrugs. * **Active Metabolites:** Enalaprilat (the active form of Enalapril) is available only as an intravenous formulation for hypertensive emergencies because it has poor oral absorption. * **Common Prodrugs to Remember:** Levodopa (to Dopamine), Clopidogrel, Prednisone (to Prednisolone), Cyclophosphamide, and Valacyclovir. * **Advantage of Prodrugs:** They are often designed to increase absorption, decrease gastrointestinal toxicity, or prolong the duration of action.

Question 203: Autoinduction of biotransformation and action as a hormone is seen in:

A. Carbamazepine
B. Cimetidine
C. Corticosteroid
D. Thyroxine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Thyroxine (D)**. This question tests the dual understanding of metabolic pathways and endocrine physiology. **Why Thyroxine is correct:** 1. **Autoinduction:** Thyroxine ($T_4$) is a unique example of a substance that induces its own metabolism. It stimulates the expression of enzymes responsible for its deiodination and glucuronidation, leading to a self-regulated metabolic rate. 2. **Hormonal Action:** Thyroxine is an endogenous hormone produced by the thyroid gland. It acts on nuclear receptors (TR-$\alpha$ and TR-$\beta$) to regulate gene transcription, affecting basal metabolic rate, growth, and development. **Analysis of Incorrect Options:** * **Carbamazepine (A):** While it is a classic and potent **autoinducer** of CYP3A4 enzymes (leading to a decrease in its own half-life over the first few weeks of therapy), it is a synthetic anticonvulsant drug, not a hormone. * **Cimetidine (B):** This is a potent **enzyme inhibitor** (not an inducer). It inhibits various CYP450 isoenzymes, leading to increased levels of drugs like warfarin and theophylline. * **Corticosteroids (C):** These are hormones (e.g., cortisol) and can induce the metabolism of *other* drugs (enzyme induction), but they are not typically characterized by the specific phenomenon of autoinduction in clinical pharmacology. **NEET-PG High-Yield Pearls:** * **Autoinducers to remember:** Carbamazepine, Phenobarbitone, Rifampicin, and Thyroxine. * **Mechanism of Thyroxine:** It is a pro-hormone; the more active form is $T_3$ (Triiodothyronine), converted via 5'-deiodinase. * **Clinical Note:** Due to autoinduction, the dose of Carbamazepine may need adjustment after the first 2–4 weeks of treatment as plasma levels may drop despite constant dosing.

Question 204: What is the volume of distribution for chloroquine?

A. 5–8 L
B. 9–15 L
C. 100–650 L
D. Above 1300 L (Correct Answer)

Explanation: **Explanation:** The **Volume of Distribution ($V_d$)** is a theoretical volume that relates the amount of drug in the body to its concentration in the plasma. Chloroquine has an exceptionally high $V_d$ (typically cited between **1300 L to 15,000 L**) because it is highly lipid-soluble and undergoes extensive sequestration into tissues, particularly the liver, spleen, kidneys, and melanin-containing tissues like the retina. **Why Option D is correct:** A $V_d$ exceeding total body water (~42 L) indicates that the drug is not confined to the plasma but is distributed deep into peripheral tissues. Chloroquine’s massive $V_d$ (Above 1300 L) reflects its high tissue binding, which also explains its prolonged half-life (1–2 months). **Why other options are incorrect:** * **Options A & B (5–15 L):** These values represent drugs confined primarily to the plasma (e.g., Heparin) or extracellular fluid (e.g., Aminoglycosides). * **Option C (100–650 L):** While this indicates significant tissue distribution (e.g., Digoxin ~500 L), it still underestimates the extreme sequestration characteristic of Chloroquine. **High-Yield Clinical Pearls for NEET-PG:** * **Loading Dose:** Drugs with a high $V_d$ like Chloroquine require a loading dose to achieve therapeutic plasma concentrations quickly. * **Hemodialysis:** Drugs with a high $V_d$ cannot be effectively removed by hemodialysis because very little drug is present in the circulation. * **Toxicity:** Due to its affinity for melanin, long-term Chloroquine use can lead to **"Bull’s eye maculopathy"** (retinal toxicity). * **Other drugs with high $V_d$:** Digoxin, Amiodarone, and Tricyclic Antidepressants (TCAs).

Question 205: Which of the following is true regarding the receptor action of a drug?

A. An antagonist has both intrinsic activity and affinity for a receptor.
B. An antagonist has affinity but no intrinsic activity for a receptor. (Correct Answer)
C. A partial antagonist has no intrinsic activity or affinity for a receptor.
D. Intrinsic activity and affinity are not important for drug action.

Explanation: ### Explanation To understand drug-receptor interactions, two key parameters are essential: **Affinity** (the ability of a drug to bind to a receptor) and **Intrinsic Activity/Efficacy** (the ability of a drug to activate the receptor and produce a biological response). **1. Why Option B is Correct:** An **Antagonist** is a ligand that binds to a receptor (possesses **Affinity**) but fails to activate it (possesses **Zero Intrinsic Activity**). By occupying the receptor site, it prevents the binding of an endogenous agonist, thereby blocking its effect. **2. Analysis of Incorrect Options:** * **Option A:** This describes an **Agonist**. Agonists have both affinity and maximal intrinsic activity (IA = 1). * **Option C:** This is incorrect because a **Partial Agonist** (often confused here with "partial antagonist") has affinity and *submaximal* intrinsic activity (IA between 0 and 1). It acts as an antagonist only in the presence of a full agonist. * **Option D:** This is fundamentally wrong. These two parameters are the pillars of pharmacodynamics; affinity determines the **potency**, while intrinsic activity determines the **maximal efficacy** of a drug. **3. NEET-PG High-Yield Pearls:** * **Intrinsic Activity (IA) Values:** * Full Agonist: IA = 1 * Antagonist: IA = 0 * Partial Agonist: IA = >0 to <1 * Inverse Agonist: IA = -1 (produces an effect opposite to the agonist). * **Competitive Antagonism:** Shifts the dose-response curve to the **right** (increases $EC_{50}$, potency decreases, but maximal efficacy remains unchanged). * **Non-competitive Antagonism:** Shifts the curve **downwards** (maximal efficacy decreases).

Question 206: Therapeutic drug monitoring is advised in all drugs except which one of the following?

A. Metformin (Correct Answer)
B. Phenytoin
C. Tacrolimus
D. Cyclosporine

Explanation: **Explanation:** Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in the blood to maintain a constant concentration within a specific **narrow therapeutic window**. **Why Metformin is the Correct Answer:** Metformin is a biguanide used for Type 2 Diabetes. TDM is **not** required for Metformin because its clinical effect (blood glucose levels) can be easily and directly measured using a surrogate marker (HbA1c or blood sugar levels). Furthermore, Metformin has a **wide therapeutic index**, meaning the dose required for efficacy is far below the dose that causes toxicity. **Analysis of Incorrect Options:** * **Phenytoin:** This antiepileptic drug follows **zero-order (non-linear) kinetics** at therapeutic doses. Small dose increments can lead to disproportionately large increases in plasma concentration, necessitating TDM to avoid cerebellar toxicity. * **Tacrolimus & Cyclosporine:** These are calcineurin inhibitors (immunosuppressants) with a **narrow therapeutic index**. Sub-therapeutic levels lead to graft rejection, while supra-therapeutic levels cause significant nephrotoxicity and neurotoxicity. TDM is mandatory for these drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Drugs with a narrow therapeutic index, non-linear kinetics, high inter-individual variation, or when toxicity is difficult to distinguish from the disease itself (e.g., Digoxin). * **Drugs requiring TDM (Mnemonic: "The LiP DiT"):** **The**ophylline, **Li**thium, **P**henytoin, **D**igoxin, **I**mmunosuppressants (Tacrolimus/Cyclosporine), **T**ricyclic Antidepressants. * **TDM is NOT needed when:** The drug has a wide therapeutic index or when the pharmacological effect is easily measurable (e.g., BP for antihypertensives, INR for Warfarin, Blood sugar for Metformin).

Question 207: Phase-2 reactions in drug metabolism are primarily characterized by which of the following processes?

A. Oxidation
B. Hydroxylation
C. Cyclization
D. Conjugation (Correct Answer)

Explanation: ### Explanation Drug metabolism (biotransformation) typically occurs in two phases to convert lipid-soluble drugs into water-soluble metabolites for excretion. **1. Why Conjugation is Correct:** Phase-2 reactions are **synthetic reactions** where an endogenous hydrophilic group is attached to the drug or its Phase-1 metabolite. This process is known as **Conjugation**. The primary goal is to significantly increase the polarity and water solubility of the compound, facilitating its excretion via urine or bile. Common Phase-2 reactions include Glucuronidation (most common), Acetylation, Methylation, and Sulfation. **2. Why Other Options are Incorrect:** * **Oxidation (A), Hydroxylation (B), and Cyclization (C):** These are all examples of **Phase-1 (Non-synthetic) reactions**. Phase-1 reactions involve the introduction or unmasking of a functional group (like -OH, -NH2, or -SH) through oxidation, reduction, or hydrolysis. These reactions usually utilize the **Cytochrome P450** enzyme system and often result in metabolites that are still chemically active. **3. High-Yield Clinical Pearls for NEET-PG:** * **Glucuronidation:** The most common Phase-2 reaction; it is the only one that occurs in the microsomal fraction (Smooth Endoplasmic Reticulum). All other Phase-2 reactions are non-microsomal (cytosolic). * **Acetylation:** Shows genetic polymorphism (Fast vs. Slow acetylators). Drugs like **Isoniazid, Hydralazine, and Procainamide** (Mnemonic: **SHIP**) undergo acetylation. * **Exceptions:** Most drugs follow Phase-1 followed by Phase-2. However, **Isoniazid** undergoes Phase-2 (Acetylation) before Phase-1 (Hydrolysis). * **Morphine-6-Glucuronide:** A rare example where a Phase-2 metabolite is more pharmacologically active than the parent drug.

Question 208: What is the most common Phase I biotransformation reaction?

A. Oxidation (Correct Answer)
B. Hydrolysis
C. Cyclisation
D. Reduction

Explanation: **Explanation:** Drug metabolism (biotransformation) occurs in two phases. **Phase I reactions** (Non-synthetic) involve the introduction or unmasking of a functional group (–OH, –NH2, –SH) to make the molecule more polar. Among these, **Oxidation** is the most common and important Phase I reaction. It is primarily mediated by the **Cytochrome P450 (CYP450)** enzyme system located in the smooth endoplasmic reticulum of hepatocytes. **Analysis of Options:** * **Oxidation (Correct):** It involves the addition of oxygen or removal of hydrogen. It is the predominant pathway for most drugs (e.g., Phenytoin, Barbiturates). * **Reduction:** This involves the addition of hydrogen or removal of oxygen. It is less common than oxidation but important for drugs like Chloramphenicol and Halothane. * **Hydrolysis:** This is the cleavage of a bond by adding water. It occurs in the plasma or tissues for esters (e.g., Procaine, Aspirin) and amides (e.g., Lidocaine). * **Cyclisation:** This is a minor Phase I reaction involving the formation of a ring structure from a straight chain (e.g., Proguanil). **High-Yield Clinical Pearls for NEET-PG:** * **Phase I vs. Phase II:** Phase I reactions generally result in metabolites that are active, inactive, or even more toxic. Phase II (Conjugation) reactions almost always result in **inactive, highly polar, and easily excretable** metabolites. * **Glucuronidation:** While Oxidation is the most common Phase I reaction, **Glucuronide conjugation** is the most common Phase II reaction. * **Microsomal Enzymes:** CYP3A4 is the most abundant CYP isoform in the liver and is responsible for metabolizing nearly 50% of all clinically used drugs. * **Exception:** Most drugs undergo Phase I followed by Phase II, but some (like Isoniazid) undergo Phase II (Acetylation) before Phase I (Hydrolysis).

Question 209: What is the value of intrinsic activity for a partial agonist?

A. 1
B. 0
C. Between 0 and +1 (Correct Answer)
D. -1

Explanation: ### Explanation **Intrinsic Activity (α)** refers to the ability of a drug to activate a receptor and produce a maximal biological response once it has bound to it. It is measured on a scale from -1 to +1. **Why the Correct Answer is Right:** A **Partial Agonist** binds to a receptor but, even at 100% receptor occupancy, it cannot elicit the maximal response (Emax) that a full agonist would. Therefore, its intrinsic activity is greater than zero (it does produce a response) but less than one (the response is sub-maximal). * **Mathematical Value:** 0 < α < 1. * **Clinical Significance:** In the presence of a full agonist, a partial agonist acts as a **competitive antagonist** because it occupies receptors but produces a weaker effect, effectively "damping" the overall response (e.g., Buprenorphine in opioid use). **Why Other Options are Wrong:** * **Option A (1):** This is the intrinsic activity of a **Full Agonist**, which produces the maximum possible biological response. * **Option B (0):** This is the intrinsic activity of a **Competitive Antagonist**. It has affinity (binds to the receptor) but zero intrinsic activity (produces no response). * **Option D (-1):** This is the intrinsic activity of an **Inverse Agonist**. It binds to the receptor and produces an effect opposite to that of an agonist (decreases constitutive activity). **High-Yield NEET-PG Pearls:** 1. **Affinity vs. Intrinsic Activity:** All agonists and antagonists have affinity, but only agonists (full/partial/inverse) have intrinsic activity. 2. **Pindolol:** A classic example of a partial agonist (Beta-blocker with Intrinsic Sympathomimetic Activity). 3. **Varenicline:** A partial agonist at nicotinic receptors used for smoking cessation. 4. **Aripiprazole:** An atypical antipsychotic that acts as a partial agonist at $D_2$ receptors.

Question 210: What is the duration of action of omeprazole?

A. 1-2 hours
B. 4-8 hours
C. 8-16 hours
D. 24-48 hours (Correct Answer)

Explanation: **Explanation:** The duration of action of Omeprazole is **24-48 hours**, despite its remarkably short plasma half-life (approx. 1-1.5 hours) [1]. This discrepancy is a classic example of a **"Hit and Run" drug**. **Why D is correct:** Omeprazole is a Proton Pump Inhibitor (PPI) that acts as an irreversible inhibitor of the **H+/K+ ATPase pump** in gastric parietal cells [1], [2]. As a prodrug, it is activated in the acidic canaliculi and forms a covalent disulfide bond with the pump [1], [2]. Because the inhibition is **irreversible**, acid secretion can only resume once the parietal cell synthesizes *new* pump proteins [1], [2]. This biological turnover takes significantly longer than the time the drug remains in the blood, leading to a prolonged clinical effect (24-48 hours). **Why other options are incorrect:** * **A (1-2 hours):** This reflects the **plasma half-life** ($t_{1/2}$) of the drug, not its pharmacodynamic duration of action [1]. * **B & C (4-16 hours):** These durations are too short for an irreversible inhibitor. While acid suppression begins quickly, the peak effect and the time required for pump regeneration extend well beyond 16 hours. **High-Yield Clinical Pearls for NEET-PG:** * **Activation:** PPIs are acid-labile prodrugs; they require an acidic environment for activation but must be administered in enteric-coated forms to prevent premature degradation in the stomach lumen [1], [2]. * **Timing:** They should be taken **30-60 minutes before a meal** (usually breakfast) to ensure peak drug levels coincide with the maximal activation of proton pumps during feeding [1]. * **Drug Interaction:** Omeprazole inhibits **CYP2C19**, which can reduce the activation of the antiplatelet drug **Clopidogrel**.

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free